Mental health advocates are lobbying Congress to help them get schizophrenia classified as a brain disease like Parkinson or Alzheimer disease, instead of as a mental illness; the annual Consumer Electronics Show, which begins this week in Las Vegas, has become an increasingly popular place for health technology firms looking for publicity in the $7 trillion global medical industry; the Trump administration warned scientists doing biomedical research at American universities that Chinese spies may be trying to steal and exploit information.
Mental health advocates are lobbying Congress to help them get schizophrenia classified as a brain disease like Parkinson or Alzheimer disease, instead of as a mental illness, Politico reported. The Schizophrenia and Related Disorders Alliance of America is among those pushing Congress to include schizophrenia in a new CDC program that aims to collect data on the prevalence and risk factors of neurological conditions in the United States, a move that could reduce stigma and lead to more funding for a cure. The problem is that the CDC only has enough money to study a finite number of conditions, putting disease advocacy groups in competition with each other.
The annual Consumer Electronics Show, which begins this week in Las Vegas, has become an increasingly popular place for health technology firms looking for publicity in the $7 trillion global medical industry, STAT News reported. This year brings a particular focus on chronic disease, but some experts warn that the real-world results of digital health products have not caught up to their promises. Companies will feature products targeting heart monitoring, diabetes, and nonopioid management of chronic pain.
The Trump administration warned scientists doing biomedical research at American universities that Chinese spies may be trying to steal and exploit information, The New York Times reported. Scientists and universities receiving National Institutes of Health funding need to tighten their security procedures and take other precautions, said a panel of experts commissioned by the agency to investigate “foreign influences on research integrity.”
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen